HomeDarifenacin HydrobromideDarifenacin Hydrobromide + Midazolam

Does Darifenacin Hydrobromide Interact with Midazolam?

Darifenacin Hydrobromide and Midazolam have a minor drug interaction according to U.S. FDA drug labeling data. CYP3A4 substrate. Darifenacin did not have significant impact on midazolam pharmacokinetics. The mechanism involves cyp3a4 substrate. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Minor
Midazolam Class
Benzodiazepine
Management
Generally manageable
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Darifenacin Hydrobromide and Midazolam occurs because cyp3a4 substrate. Clinically, this means cyp3a4 substrate. darifenacin did not have significant impact on midazolam pharmacokinetics. This is classified as a minor interaction with generally low clinical significance, though your healthcare provider should still be informed that you are taking both medications.

What To Tell Your Doctor or Pharmacist

If you are taking Darifenacin Hydrobromide and your doctor is considering prescribing Midazolam (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Never stop or change either medication without first consulting your healthcare provider
💊 Darifenacin Hydrobromide(Darifenacin)+💊 Midazolam

Severity & Interaction Details

minor
Generally safe — minor interaction
Low clinical significance. Routine awareness is usually sufficient.
Severity scale
MinorContra
On record
Yes
Drug A class
Drug B class
Benzodiazepine
Source
NLP:darifenacin hydrobromide

What this means in plain English

CYP3A4 substrate. Darifenacin did not have significant impact on midazolam pharmacokinetics.

What the FDA label says

"CYP3A4 substrate"

📖 Source: NLP:darifenacin hydrobromide

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Darifenacin Hydrobromide and Midazolam against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.